SCHEMBL4178951

SCHEMBL4178951

N#C/C(=C\c1ccoc1)S(=O)(=O)Cc1ccc(Cl)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.39
▸ KMT2A Q03164 5/20 0.38
▸ POLB P06746 3/20 0.38
▸ MAPT P10636 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ ERCC1 P07992 1/20 0.37
▸ ERCC4 Q92889 1/20 0.37
▸ PKM P14618 3/20 0.33
▸ GABRA1 P14867 2/20 0.33
▸ GABRG2 P18507 2/20 0.33
▸ GABRB3 P28472 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ P2RX7 Q99572 2/20 0.32
▸ THRB P10828 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178957 1.00 HSD11B1 (0.39) HSD11B1KMT2APOLBMAPTMEN1
SCHEMBL4178955 1.00 HSD11B1 (0.39) HSD11B1KMT2APOLBMAPTMEN1
SCHEMBL4182619 0.86 HSD11B1 (0.43) HSD11B1KMT2APOLBMAPTMEN1
SCHEMBL4182627 0.86 HSD11B1 (0.43) HSD11B1KMT2APOLBMAPTMEN1
SCHEMBL4182624 0.86 HSD11B1 (0.43) HSD11B1KMT2APOLBMAPTMEN1
SCHEMBL4177863 0.84 L3MBTL1 (0.41) HSD11B1KMT2AMAPTMEN1L3MBTL1
SCHEMBL4177867 0.84 L3MBTL1 (0.41) HSD11B1KMT2AMAPTMEN1L3MBTL1
SCHEMBL4177859 0.84 L3MBTL1 (0.41) HSD11B1KMT2AMAPTMEN1L3MBTL1
SCHEMBL4186118 0.83 ALDH1A1 (0.42) HSD11B1KMT2APOLBMAPTMEN1
SCHEMBL4186115 0.83 ALDH1A1 (0.42) HSD11B1KMT2APOLBMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US claimed
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 HSD11B1 1293/4885KMT2A 469/4885POLB 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback